Asthma Management Handbook

Highlights of Version 1.2 update

Version 1.2 of the Australian Asthma Handbook, published October 2016, is a minor update to version 1.1, published in April 2015.

Table. Australian Asthma Handbook Version 1.2 clinical amendments Opens in a new window Please view and print this figure separately: https://www.asthmahandbook.org.au/table/show/99

Table. Australian Asthma Handbook Version 1.2 minor amendments Opens in a new window Please view and print this figure separately: https://www.asthmahandbook.org.au/table/show/100

Table. Australian Asthma Handbook Version 1.2 clinical amendments (additional amendments published March 2017) Opens in a new window Please view and print this figure separately: https://www.asthmahandbook.org.au/table/show/101

Summary of key clinical changes and clarifications

Clarification of long-term use of low-dose ICS in adults

Amendments to clarify advice that long-term (including lifetime) low-dose ICS treatment may be needed, and to provide more detailed guidance on what is meant by low-dose for ICS in adults. Also, to emphasise that the purpose of long-term low-dose ICS is to reduce future risk rather than to treat current symptoms.

Emphasis on written asthma action plans

Restructured website menus to give more prominence to the central recommendation that every patient should have a personalised written asthma action plan.

Update of advice on inhaler technique

Amendments to reflect the National Asthma Council's 2016 information paper on Inhaler technique for people with asthma or COPD, and to clarify advice on priming new spacers.

Inclusion of new treatment options

Amendments and additions to incorporate new medications and/or indications for fluticasone furoate, mepolizumab, omalizumab and tiotropium, and to incorporate new specific allergen immunotherapy preparations. 

Inclusion of advice on e-cigarettes

Additions to incorporate use of e-cigarettes and provide interim consensus advice until more evidence becomes available. 

Other minor amendments 

Other minor amendments, including:

  • Simplification of oxygen therapy advice in acute asthma
  • Clarification of information on asthma control questionnaires
  • Update in terminology for coexisting asthma and COPD
  • Update of infant feeding and allergy prevention advice to reflect new ASCIA guidelines
  • Increased prominence of warnings about potential adverse psychiatric effects of montelukast in children
  • Various spelling and terminology updates